Skip to content
Screener

Novanta NOVT Automation Enabling Technologies — Selling General And Administrative Expense

Similar metrics at other companies

Modine Manufacturing logo
MODPerformance Technologies — Selling General And Administrative Expense
$19.5M-11.0%
Chemours logo
CCTitanium Technologies — Selling General And Administrative Expense
$29M0.0%
Select Water Solutions logo
WTTRChemical Technologies — Selling General And Administrative Expense
$4.19M-8.6%
Flowco Holdings logo
FLOCNatural Gas Technologies — Selling General And Administrative Expense
$7.23M-28.1%
Bruker logo
BRKREnergy And Supercon Technologies — Selling General And Administrative Expense
$5.8M+1.8%
Phibro Animal Health logo
PAHCMineral Nutrition — Selling General And Administrative Expense
$1.99M+0.7%

Other financials

Income statement

See full
Revenue$265.8M+10.3%
Gross profit$120.9M+13.3%
Operating income$18.1M+21.1%
Net income$12.5M+179%
EPS (diluted)$0.30+150%

Balance sheet

See full
Cash & equivalents$718.7M+554%
Total debt$285.6M-44.5%
Total equity$1.6B+102%
Total assets$2.1B+41.6%

Cash flow

See full
Operating cash flow$64.9M+331%
CapEx$7.5M+120%
Free cash flow$57.5M+392%

Valuation

See full
Market cap$5.82B+42.2%
Enterprise value$5.38B+19.7%
P/E94.2×+27.5×
P/S5.7×+1.4×

Profitability

See full
Gross margin44.5%-0.2pp
Operating margin9%-2.2pp
Net margin6%-0.4pp
FCF margin11.1%-1.2pp

Returns & leverage

See full
Return on equity5.1%-3.1pp
Debt / equity0.2×-0.5×
Current ratio4.6×+2.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Novanta’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335404
Line itemThree Months Ended July 3, 2026 / Automation Enabling TechnologiesThree Months Ended July 3, 2026 / Medical SolutionsThree Months Ended July 3, 2026 / TotalSix Months Ended July 3, 2026 / Automation Enabling TechnologiesSix Months Ended July 3, 2026 / Medical SolutionsSix Months Ended July 3, 2026 / Total
Amortization of purchased intangible assets1,2002,5552,4005,114
Segment gross profit71,59650,323121,919134,352102,498236,850
Research and development and engineering9,49614,66718,52828,915
Selling, general and administrative20,78416,58540,67332,891
Amortization of purchased intangible assets2,7043,7114,8237,366
Restructuring, acquisition, and related costs2,0201,7532,5832,993
Segment operating income36,59213,60750,19967,74530,33398,078
Unallocated costs(32,138)(52,478)

Item 1. Financial Statements

FAQ

What is Novanta's automation enabling technologies — selling general and administrative expense?
Novanta (NOVT) reported automation enabling technologies — selling general and administrative expense of $20.78M in Q2 2026.
How has Novanta's automation enabling technologies — selling general and administrative expense changed year-over-year?
Novanta's automation enabling technologies — selling general and administrative expense increased by 13.4% year-over-year, from $18.33M to $20.78M.
What is the long-term trend for Novanta's automation enabling technologies — selling general and administrative expense?
Over 3 years (2022 to 2025), Novanta's automation enabling technologies — selling general and administrative expense has grown at a 1.2% compound annual growth rate (CAGR), from $73.55M to $76.32M.
What does automation enabling technologies — selling general and administrative expense mean?
Operating expenses for the Automation Enabling Technologies segment that are not directly tied to production, including sales, marketing, and general corporate overhead. This metric reflects the segment's operational leverage and administrative efficiency.

Ask your AI about Novanta's automation enabling technologies — selling general and administrative expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude